Loading...
XETR
EVK
Market cap9.32bUSD
Apr 08, Last price  
18.24EUR
1D
1.84%
1Q
9.81%
Jan 2017
-35.73%
IPO
-43.35%
Name

Evonik Industries

Chart & Performance

D1W1MN
P/E
38.29
P/S
0.56
EPS
0.48
Div Yield, %
6.41%
Shrs. gr., 5y
-0.06%
Rev. gr., 5y
2.95%
Revenues
15.16b
-0.72%
14,125,000,00014,430,000,00015,873,000,00013,076,000,00013,300,000,00014,540,000,00013,629,000,00012,874,000,00012,917,000,00013,507,000,00012,732,000,00014,419,000,00015,024,000,00013,108,000,00012,199,000,00014,955,000,00018,488,000,00015,267,000,00015,157,000,000
Net income
222m
P
1,046,000,000876,000,000285,000,000240,000,000734,000,0001,011,000,0001,164,000,0002,054,000,000568,000,000991,000,000844,000,000717,000,000932,000,000774,000,000465,000,000746,000,000540,000,000-465,000,000222,000,000
CFO
1.71b
+7.47%
1,142,000,0001,215,000,000388,000,0002,092,000,0002,075,000,0001,309,000,0001,420,000,0001,083,000,0001,066,000,0001,971,000,0001,758,000,0001,551,000,0001,704,000,0001,321,000,0001,727,000,0001,815,000,0001,650,000,0001,594,000,0001,713,000,000
Dividend
May 29, 20250 EUR/sh
Earnings
May 12, 2025

Profile

Evonik Industries AG engages in the specialty chemicals business. It operates through Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure segments. The Specialty Additives segment provides polyurethane additives, organically modified silicones, isophorones, epoxy curing agents, oil additives, fumed silicas, matting agents, TAA and TAA derivatives, and acetylenic diol-based surfactants for consumer goods and specialized industrial applications. The Nutrition & Care segment offers amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, animal nutrition, and healthcare products. The Smart Materials segment provides hydrogen peroxide, peracetic acid, activated nickel catalysts, precious metal powder catalysts, oil and fat hydrogenation catalysts, amorphous polyalphaolefins, polybutadienes, polyester resins, thermoplastic and reactive methacrylate resins, PEEK, polyamide 12, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, and precipitated silicas for the automotive, paints, coatings, adhesives, construction, and various other sectors. The Performance Materials segment produces polymer materials and intermediates, including butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbent for rubber, plastics, and automotive industries. The Technology & Infrastructure segment provides site management, utilities and waste management, technical, process technology, engineering, and logistics services. It operates in the Asia-Pacific, Europe, the Middle East, Africa, Central and South America, and North America. The company was founded in 1873 and is headquartered in Essen, Germany. Evonik Industries AG is a subsidiary of RAG-Stiftung.
URL
https://corporate.evonik.com
IPO date
May 01, 2013
Employees
33,357
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
15,157,000
-0.72%
15,267,000
-17.42%
18,488,000
23.62%
Cost of revenue
14,552,000
14,652,000
17,306,000
Unusual Expense (Income)
NOPBT
605,000
615,000
1,182,000
NOPBT Margin
3.99%
4.03%
6.39%
Operating Taxes
194,000
101,000
369,000
Tax Rate
32.07%
16.42%
31.22%
NOPAT
411,000
514,000
813,000
Net income
222,000
-147.74%
(465,000)
-186.11%
540,000
-27.61%
Dividends
(545,000)
(545,000)
(545,000)
Dividend yield
7.01%
6.32%
6.52%
Proceeds from repurchase of equity
(3,000)
(4,000)
(4,000)
BB yield
0.04%
0.05%
0.05%
Debt
Debt current
837,000
952,000
184,000
Long-term debt
3,862,000
4,232,000
4,992,000
Deferred revenue
134,000
134,000
146,000
Other long-term liabilities
2,875,000
4,192,000
2,255,000
Net debt
3,729,000
3,659,000
4,042,000
Cash flow
Cash from operating activities
1,713,000
1,594,000
1,650,000
CAPEX
(840,000)
(793,000)
(865,000)
Cash from investing activities
(663,000)
(653,000)
(777,000)
Cash from financing activities
(1,330,000)
(823,000)
(672,000)
FCF
232,000
1,392,000
(266,000)
Balance
Cash
618,000
1,033,000
1,120,000
Long term investments
352,000
492,000
14,000
Excess cash
212,150
761,650
209,600
Stockholders' equity
7,972,000
8,986,000
9,893,000
Invested Capital
15,677,850
16,797,350
17,054,400
ROIC
2.53%
3.04%
4.74%
ROCE
3.66%
3.39%
6.59%
EV
Common stock shares outstanding
464,583
466,000
466,000
Price
16.73
-9.62%
18.51
3.23%
17.93
-37.02%
Market cap
7,772,479
-9.89%
8,625,660
3.23%
8,355,380
-37.02%
EV
11,581,479
12,360,660
12,484,380
EBITDA
1,722,000
1,713,000
2,750,000
EV/EBITDA
6.73
7.22
4.54
Interest
212,000
108,000
121,000
Interest/NOPBT
35.04%
17.56%
10.24%